With the rise in the aging population, osteoporosis has become a major health burden. From 50 years of age onward, 4 in 10 women will have a hip, vertebral, or forearm fracture. And in the years to come, they are more likely to die from complications as a consequence of fracture rather than from breast cancer. Although osteoporosis is viewed as a disease occurring in post-menopausal women, men account for 30%of hip fractures worldwide (1). More importantly, osteoporosis causes a greater health burden in older people. Billions of dollars are spent each year in the US on acute and long-term care required for people who sustain osteoporosisrelated fractures (2). Globally, osteoporotic fractures caused an estimated 5.8 million disability adjusted life years in the year 2000 (3). This fi gure is expected to increase worldwide as the population ages. Fractures, as a result of osteoporosis, consume a signifi cant proportion of healthcare resources. Recently, the annual cost of all osteoporotic fractures in the US has been estimated to be $20 billion (2). In 1995, more than 400,000 hospitalizations, 3.4 million outpatient visits, and 179,000 nursing home admissions were a direct consequence of osteoporotic fractures (1). Hip fractures have the highest morbidity and mortality. Almost all of the hip fractures occur after a fall; 80% occur amongst women and 90% occur in people over the age of 50 (2). People with hip fractures have 12–39% higher mortality in the immediate following year compared to the same age population; 13–50% of survivors are not able to walk after the event and 12–20% of the survivors need nursing home placement (2). Vertebral fractures are the most common osteoporotic fractures. Many are not recognized clinically. Whether recognized clinically or not, they cause pain, height loss, deformity, and increased risk for further fractures (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Colon-Emeric CS, Saag KG. Osteoporotic fractures in older adults. Best Prac Res Clin Rheumatol 2006;20:695–706.
Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010–2018.
Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 2000;11:551– 552.
Lyles KW, Gold DT, Shipp KM, et al. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med 1993;94: 595–601.
Chan GK, Duque G. Age-related bone loss: old bone, new facts. Gerontology 2002;48:62–71.
Tidermark J, Ponzer S, Carlsson P, et al. Effects of protein-rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clin Nutr 2004;23:587–596.
Sambrook PN, Cameron ID, Chen JS, et al. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int 2007;18)5):603–610.
Court-Brown CM, Caesar B. Epidemiology of adult fractures: a review. Injury 2006;37:691–697.
Brainsky A, Glick H, Lydick E, et al. The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc 1997;45:281–287.
Cooper C, Campion G, Melton LJ. Hip-fractures in the elderly—a worldwide projection. Osteoporos Int 1992;2:285–289.
Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7: 407–413.
Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2005;353:595–603.
Poole KE, Compston JE. Osteoporosis and its management. BMJ 2006;333:1251–1256.
Heffernan MP, Saag KG, Robinson JK, et al. Prevention of osteoporosis associated with chronic glucocorticoid therapy. JAMA 2006;295:1300– 1303.
No authors listed. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003;921:1–164.
Prestwood KM, Duque G. Osteoporosis. In: Textbook of principles of geriatric medicine and gerontology, 5th edition. Hazzard (ed.) New York: McGraw Hill, 2003, 973–986.
Kenny AM, Prestwood KM, Marcello KM, et al. Determinants of bone density in healthy older men with low testosterone levels. J Gerontol A Biol Sci Med Sci 2000;55:M492–M497.
Mundy GR, Elefteriou F. Boning up on ephrin signaling. Cell 2006;126:441–443.
Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 2000;27:177–184.
Delmas PD, van de Langerijt L, Watts NB, et al. IMPACT Study Group. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 2005;20:557–563.
Black DM, Steinbuch M, Palermo L, et al. An ass essment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001;12: 519–528.
De Laet CE, van Hout BA, Burger H, et al. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ 1997;315:221–225.
Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001;49:664–672.
Hillier TA, Stone KL, Bauer DC, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med 2007;167:155–160.
Pieper CF, Colon-Emeric CS, Caminis J, et al. Distribution and correlates of serum 25-hydroxyvita-min D levels in a sample of hip fracture patients. Am J Geriatr Pharmacother [In press].
Heaney RP, Dowell MS, Hale CA, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamn D. J Amer Coll Nutr 2003;22:142–146.
Gallagher JC, Rapuri PB, Smith LM. An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab 2007;92:51–58.
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999–2006.
Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234–239.
Stone LM, Lyles KW. Generations—chronic conditions in later life. Journal of the American Society on Aging. Osteoporos Int 2006;30(3):65–70.
Sjosten NM, Salonoja M, Piirtola M, et al. A multi-factorial fall prevention programme in home-dwelling elderly people: a randomized-controlled trial. Am J Public Health 2007;12:308–318.
Rubin C, Recker R, Cullen D, et al. Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. J Bone Miner Res 2004;19:343–351.
Kita K, Hujino K, Nasu T, et al. A simple protocol for preventing falls and fractures in elderly individuals with musculoskeletal disease. Osteoporos Int 2007;18(5):611–619.
Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434– 1441.
Seeman E, Vellas B, Benhamou C, et al. Strontium ranelate reduces the risk of vertebral and nonver-tebral fractures in women eighty years of age and older. J Bone Miner Res 2006;21:1113–1120.
Goltzman D. Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 2002;1:784–796.
Marcus R, Wang O, Satterwhite J, et al. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal with osteoporosis. J Bone Miner Res 2003;18:18–23.
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637– 1642.
Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257–2264.
Gompel A, Barlow D, Rozenberg S, et al. EMAS Executive Committee. The EMAS 2006/2007 update on clinical recommendations on postmeno-pausal hormone therapy. Maturitas 2007;56:227– 229.
Qu Y, Wong M, Thiebaud D, et al. The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial. Curr Med Res Opin 2005;21:1955–1959.
Gaudio A, Morabito N. Pharmacological management of severe postmenopausal osteoporosis. Drugs Aging 2005;22:405–417.
Wehren LE, Hosking D, Hochberg MC. Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Curr Med Res Opin 2004;20: 525–531.
Mulder JE, Kolatkar NS, LeBoff MS. Drug insight: existing and emerging therapies for osteoporosis. Nat Clin Pract Endocrinol Metab 2006;2:670–680.
Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for use of the antiresorptive agents in the old and oldest old. J Am Geriatr Soc 2004;52: 1832–1839.
Croom KF, Scott LJ. Intravenous ibandronate: in the treatment of osteoporosis. Drugs 2006;66: 1593–1601.
Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753–761.
Bilezikian JP. Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med 2006;355:2278–2281.
Stokkers PC, Deley M, Van Der Spek M, et al. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflam-matory bowel disease. Scand J Gastroenterol 2006; 41:200–204.
Colon-Emeric CS, Caminis J, Suh TT, et al. HORIZON Recurrent Fracture Trial. The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. Curr Med Res Opin 2004;20:903–910.
Cranney A, Papaioannou A, Zytaruk N, et al. Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ 2006;175:52–59.
Shoback D. Update in osteoporosis and metabolic bone disorders. J Clin Endocrinol Metab 2007; 92:747–753.
Kanis JA, Black D, Cooper C, et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 2002;13:527–536.
Green AD, Colon-Emeric CS, Bastian L, et al. Does this woman have osteoporosis? JAMA 2004;292: 2890–2900.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Patel, R.H., Lyles, K.W. (2009). Senile Osteoporosis as a Geriatric Syndrome. In: Duque, G., Kiel, D.P. (eds) Osteoporosis in Older Persons. Springer, London. https://doi.org/10.1007/978-1-84628-697-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-84628-697-1_6
Publisher Name: Springer, London
Print ISBN: 978-1-84628-515-8
Online ISBN: 978-1-84628-697-1
eBook Packages: MedicineMedicine (R0)